Related Experiment Video
Updated: Sep 3, 2025

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Phenotyping the hypertensive heart
Marijana Tadic1, Cesare Cuspidi2, Thomas H Marwick3,4
1Klinik für Innere Medizin II, Universitätsklinikum Ulm, Albert-Einstein Allee 23, 89081 Ulm, Germany.
Insights
Advanced echocardiography techniques detect subclinical left ventricular impairment in patients with arterial hypertension. Early detection of cardiac remodelling can guide treatment to prevent cardiovascular events.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Hypertension Research
Background:
- Arterial hypertension is a primary cardiovascular risk factor, contributing significantly to global disease burden.
- Echocardiography is the standard for assessing cardiac damage in hypertensive individuals.
- Subclinical left ventricular (LV) impairment is a key concern in hypertensive heart disease (HHD).
Purpose of the Study:
- To review advanced imaging techniques for evaluating cardiac injury in arterial hypertension.
- To highlight the role of novel echocardiographic methods in detecting subclinical LV impairment.
- To discuss the differential diagnosis of LV hypertrophy in hypertensive patients.
Main Methods:
- Review of current literature on advanced echocardiography (2D/3D speckle tracking, myocardial work).
- Discussion of multimodality imaging (cardiac MRI, CT) for tissue characterization.
- Analysis of imaging findings in the context of cardiovascular event genesis.
Main Results:
- Novel echocardiographic techniques offer insights into subclinical LV impairment missed by conventional methods.
- Cardiac remodelling detected by imaging represents intermediate stages toward cardiovascular events.
- Multimodality imaging aids in distinguishing hypertensive heart disease from other causes of LV hypertrophy.
Conclusions:
- Advanced imaging, including novel echocardiography and tissue characterization, improves HHD detection.
- Identifying and treating cardiac remodelling can prevent or delay progressive disease and cardiovascular events.
- Selective use of multimodality imaging is crucial for guiding treatment and avoiding disease progression.
Abstract:
Arterial hypertension remains the most frequent cardiovascular (CV) risk factor, and is responsible for a huge global burden of disease. Echocardiography is the first-line imaging method for the evaluation of cardiac damage in hypertensive patients and novel techniques, such as 2D and D speckle tracking and myocardial work, provide insight in subclinical left ventricular (LV) impairment that would not be possible to detect with conventional echocardiography. The structural, functional, and mechanical cardiac remodelling that are detected with imaging are intermediate stages in the genesis of CV events, and initiation or intensification of antihypertensive therapy in response to these findings may prevent or delay progressive remodelling and CV events. However, LV remodelling-especially LV hypertrophy-is not specific to hypertensive heart disease (HHD) and there are circumstances when other causes of hypertrophy such as athlete heart, aortic stenosis, or different cardiomyopathies need exclusion. Tissue characterization obtained by LV strain, cardiac magnetic resonance, or computed tomography might significantly help in the distinction of different LV phenotypes, as well as being sensitive to subclinical disease. Selective use of multimodality imaging may therefore improve the detection of HHD and guide treatment to avoid disease progression. The current review summarizes the advanced imaging tests that provide morphological and functional data about the hypertensive cardiac injury.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology

